Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma
A phase 2 trial of Choline C-11 in Hepatocellular carcinoma, run by Commissariat A L'energie Atomique, with a status the registry has not verified recently.
Overview
Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma is a phase 2 interventional study registered as NCT01377220 by Commissariat A L'energie Atomique, with 30 participants planned, started 2011-06 and due to reach its primary completion in 2013-06. Interventions recorded: 11C-Choline. Conditions recorded: Hepatocellular Carcinoma.
Linked to the drug Choline C-11 because the registry names it among its interventions and Hepatocellular carcinoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialExpanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer
Shares Choline C-11 and the tag pipeline.
- TrialEfficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialOri-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialA Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unresectable HCC
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialThermal Ablation Combined With Anlotinib and TQB2450 Solution for HCC
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialNWRD06 DNA Plasmid for HCC After Curative Resection.
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialTo Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma
Shares Hepatocellular carcinoma and the tag pipeline.